DISEASE AND PREVALENCE OF CHRONIC LYMPHATIC LEUKEMIA AMONG ADULT POPULATION IN REPUBLIC OF BASHKORTOSTAN
https://doi.org/10.24060/2076-3093-2012-0-1-17-22
Abstract
The disease and prevalence analysis of chronic lymphatic leukemia from 1990 for 2009 was carried out. Considerable growth of prevalence CLL both among men and among women is established. Disease and prevalenceCLL was statistically signifi-cantly above among city dwellers, than rural. The analysis of disease and prevalence CLL on a sex has revealed higher values among men, than among women. At the analysis of CLL on age revealed that the greatest indicator is registered in a group of age 80-84 years (8,05 on 100 thousand population), the least – 25-29 years (0). Growth of disease was at the age of 45-74 and 85 years and more elder also was re-vealed and decrease of disease at the age of 75-84 years.
About the Authors
B. A. Bakirov
G.G.Kuvatov Republican Clinical Hospital
Russian Federation
Russian Federation
L. F. Latipova
G.G.Kuvatov Republican Clinical Hospital
Russian Federation
Russian Federation
References
1. Королёва Н.В. Оценка распространённости гемобластозов среди детского населения г. Северска / Н.В. Королёва. А.Б. Карпов, P.M. Тахауов, Л.Ф. Писарева // Бюллетень сибирской медицины. 2007. №2. С. 103-109.
2. Нигматуллина К.И. Заболеваемость и распространенность хроническим лимфолейкозом в Республике Башкортостан / КИ. Нигматуллина, Д.Х. Калимуллина // Башкирский химический журнал. — 2006. — Т.13. №5. – С. 117-118.
3. Нигматуллина К.И. Заболеваемость, распространенность и выживаемость при хроническом лимфолейкозе в Республике Башкортостан за 2001-2005 годы / К.И. Нигматуллина, Д.X. Калимуллина, В. Н. Ручкин // Медицинский вестник Башкортостана. 2007. №2. – С. 93-98.
4. Чигринова Е.В., Бялик Т.Е., Андреева Л.Ю., Кондратьева Т.Т., Павловская А.И., Волкова М.А. Хронический В-клеточный лимфолейкоз у лиц моложе 30 лет: агрессивное клиническое течение и рефрактерность к химиотерапии // Гематология и трансфузиология. – 2004. №3. С. 11.
5. Ahmedin Jemal, DVM, PhD; Rebecca Siegel, MPH; Jiaquan Xu, MD; Elizabeth Ward, PhD Cancer Statistics, 2010 // Ca cancer j clin. 2010. – Vol. 60. – P. 277–300.
6. de Lima M., O’Brien S., Lerner S., Keating M.J. Chronic lymphocytic leukemia in the young patient // Semin Oncol. – 1998. – Feb. – Vol. 25(1). – P. 107-116.
7. Dores G.M., Anderson W.F., Curtis, R.E., Landgren O., Ostroumova E., Bluhm E.C., Rabkin C.S., Devesa S.S. & Linet, M.S. Chronic lymphocytic leukemia and small lymphocytic lymphoma: overview of the descriptive epidemiology // British Journal of Haematology. – 2007. – Vol. 139. – P. 809–819.
8. Rozman C. Montserrat E. Chronic lymphocytic leukemia // NEJM. 1995. – Vol. 333. – P. 1052-1057.
9. Swerdlow S.H et. al. WHO classification of tumours of haematopoietic and lymphoid tissues: International Agency for Research on Cancer. Lyon, 2008.
Review
For citations:
Bakirov B.A., Latipova L.F. DISEASE AND PREVALENCE OF CHRONIC LYMPHATIC LEUKEMIA AMONG ADULT POPULATION IN REPUBLIC OF BASHKORTOSTAN. Creative surgery and oncology. 2012;(1):17-22. (In Russ.) https://doi.org/10.24060/2076-3093-2012-0-1-17-22
Views:
875
Email this article 